ExodusPoint Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.13M Buy
72,599
+70,185
+2,907% +$8.82M 0.08% 229
2025
Q1
$267K Sell
2,414
-13,430
-85% -$1.49M ﹤0.01% 1190
2024
Q4
$2.16M Buy
+15,844
New +$2.16M 0.01% 630
2024
Q3
Sell
-13,304
Closed -$1.83M 1794
2024
Q2
$1.83M Sell
13,304
-24,050
-64% -$3.31M 0.01% 703
2024
Q1
$5.15M Sell
37,354
-8,710
-19% -$1.2M 0.04% 296
2023
Q4
$6.07M Buy
46,064
+14,276
+45% +$1.88M 0.04% 272
2023
Q3
$3.58M Sell
31,788
-84,917
-73% -$9.55M 0.03% 431
2023
Q2
$11M Sell
116,705
-57,295
-33% -$5.4M 0.09% 200
2023
Q1
$17.6M Buy
174,000
+100,994
+138% +$10.2M 0.15% 120
2022
Q4
$8.72M Buy
73,006
+22,025
+43% +$2.63M 0.13% 193
2022
Q3
$5.42M Sell
50,981
-12,207
-19% -$1.3M 0.07% 352
2022
Q2
$6.16M Buy
63,188
+16,066
+34% +$1.57M 0.08% 314
2022
Q1
$4.42M Sell
47,122
-19,618
-29% -$1.84M 0.06% 395
2021
Q4
$5.68M Buy
66,740
+40,867
+158% +$3.48M 0.06% 367
2021
Q3
$2.48M Sell
25,873
-29,521
-53% -$2.83M 0.03% 602
2021
Q2
$5.39M Buy
+55,394
New +$5.39M 0.06% 289
2021
Q1
Sell
-6,983
Closed -$669K 2367
2020
Q4
$669K Sell
6,983
-11,840
-63% -$1.13M 0.01% 1009
2020
Q3
$1.81M Sell
18,823
-7,353
-28% -$707K 0.04% 400
2020
Q2
$3.19M Sell
26,176
-2,913
-10% -$355K 0.08% 261
2020
Q1
$2.52M Buy
+29,089
New +$2.52M 0.14% 120
2019
Q4
Sell
-44,746
Closed -$4.03M 1699
2019
Q3
$4.03M Buy
44,746
+6,907
+18% +$622K 0.14% 124
2019
Q2
$3.2M Sell
37,839
-14,219
-27% -$1.2M 0.13% 91
2019
Q1
$4.59M Buy
52,058
+37,225
+251% +$3.28M 0.34% 48
2018
Q4
$1.06M Buy
+14,833
New +$1.06M 0.07% 80